MEDNAX Inc  

(Public, NYSE:MD)   Watch this stock  
Find more results for MD
49.49
+1.08 (2.23%)
Nov 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 48.46 - 49.80
52 week 40.56 - 72.13
Open 48.47
Vol / Avg. 0.00/1.66M
Mkt cap 4.74B
P/E 17.55
Div/yield     -
EPS 2.82
Shares 93.66M
Beta 0.32
Inst. own 103%
Feb 5, 2018
Q4 2017 MEDNAX Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Dec 6, 2017
MEDNAX Inc at Citi Global Healthcare Conference - 2:10PM EST - Add to calendar
Nov 29, 2017
MEDNAX Inc at Bank of America Merrill Lynch Leveraged Finance Conference - 2:10PM EST - Add to calendar
Nov 14, 2017
MEDNAX Inc at Stifel Healthcare Conference - Webcast
Nov 1, 2017
Q3 2017 MEDNAX Inc Earnings Call - Webcast
Nov 1, 2017
Q3 2017 MEDNAX Inc Earnings Release
Sep 6, 2017
MEDNAX Inc at Robert W Baird Gobal Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 7.58% 10.20%
Operating margin 14.55% 17.96%
EBITD margin - 20.77%
Return on average assets 4.77% 6.57%
Return on average equity 9.18% 12.50%
Employees 7,400 -
CDP Score - -

Address

1301 Concord Ter
SUNRISE, FL 33323-2843
United States - Map
+1-954-3840175 (Phone)
+1-954-8389961 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company's national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. As of December 31, 2016, the Company had over 1,390 affiliated physicians providing anesthesia care to patients in connection with surgical and other procedures, as well as pain management. As of December 31, 2016, the Company had 270 affiliated physicians providing maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.

Officers and directors

Cesar L. Alvarez Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Joseph M. Calabro President, Chief Operating Officer
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Roger J. Medel M.D. Chief Executive Officer, Director
Age: 70
Bio & Compensation  - Reuters
Vivian Lopez-Blanco Chief Financial Officer, Treasurer
Age: 59
Bio & Compensation  - Reuters
David A. Clark President - MEDNAX National Medical Group Division
Age: 50
Bio & Compensation  - Reuters
John C. Pepia Senior Vice President, Chief Accounting Officer
Age: 54
Bio & Compensation  - Reuters
Dominic J. Andreano Senior Vice President, General Counsel, Secretary
Age: 48
Bio & Compensation  - Reuters
Manuel Kadre Lead Independent Director
Age: 51
Bio & Compensation  - Reuters
Karey D. Barker Independent Director
Age: 49
Bio & Compensation  - Reuters
Waldemar A. Carlo M.D. Independent Director
Age: 64
Bio & Compensation  - Reuters